Correlation Between TG Therapeutics and SwissCom

Can any of the company-specific risk be diversified away by investing in both TG Therapeutics and SwissCom at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TG Therapeutics and SwissCom into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between TG Therapeutics and SwissCom AG, you can compare the effects of market volatilities on TG Therapeutics and SwissCom and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TG Therapeutics with a short position of SwissCom. Check out your portfolio center. Please also check ongoing floating volatility patterns of TG Therapeutics and SwissCom.

Diversification Opportunities for TG Therapeutics and SwissCom

-0.56

Correlation Coefficient

TG Therapeutics  SwissCom

Excellent diversification

The 3 months correlation between TGTX and SwissCom is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding TG Therapeutics and SwissCom AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SwissCom AG and TG Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TG Therapeutics are associated (or correlated) with SwissCom. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SwissCom AG has no effect on the direction of TG Therapeutics i.e., TG Therapeutics and SwissCom go up and down completely randomly.

Pair Corralation between TG Therapeutics and SwissCom

Given the investment horizon of 90 days TG Therapeutics is expected to under-perform the SwissCom. In addition to that, TG Therapeutics is 4.45 times more volatile than SwissCom AG. It trades about -0.27 of its total potential returns per unit of risk. SwissCom AG is currently generating about -0.16 per unit of volatility. If you would invest  5,719  in SwissCom AG on October 15, 2024 and sell it today you would lose (126.00) from holding SwissCom AG or give up 2.2% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

TG Therapeutics  vs.  SwissCom AG

TG Therapeutics

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in TG Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, TG Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

SwissCom AG

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days SwissCom AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with TG Therapeutics and SwissCom

The main advantage of trading using opposite TG Therapeutics and SwissCom positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TG Therapeutics position performs unexpectedly, SwissCom can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SwissCom will offset losses from the drop in SwissCom's long position.

The idea behind TG Therapeutics and SwissCom AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.